The findings accentuate the PI3K/AKT pathway as a key upstream regulator, orchestrating the molecular events leading to ABCC5-mediated resistance and altered ferroptotic response in HCC cells treated with sorafenib (Huang et al., 2021). Here, ABCC5 is linked to hepatocellular carcinoma.